Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Angiodynamics Inc (NQ: ANGO ) 7.415 -0.095 (-1.26%) Streaming Delayed Price Updated: 3:57 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,113,858 Open 7.590 Bid (Size) 7.410 (26) Ask (Size) 7.420 (32) Prev. Close 7.510 Today's Range 7.290 - 8.000 52wk Range 5.260 - 9.770 Shares Outstanding 38,444,076 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Nasdaq Edges Lower; Morgan Stanley Earnings Top Views July 16, 2024 Via Benzinga Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance July 16, 2024 AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company... Via Benzinga Performance YTD -7.66% -7.66% 1 Month +25.89% +25.89% 3 Month +13.90% +13.90% 6 Month +24.83% +24.83% 1 Year -22.44% -22.44% More News Read More Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga Crude Oil Down 1%; Bank of America Posts Upbeat Earnings July 16, 2024 Via Benzinga Exposures Fossil Fuels UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday July 16, 2024 Via Benzinga ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024 July 16, 2024 Via InvestorPlace AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results July 16, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024 July 08, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System May 21, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions May 06, 2024 From AngioDynamics, Inc. Via Business Wire Insiders Buying Zumiez And 3 Other Stocks April 09, 2024 Via Benzinga Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars April 04, 2024 Via Benzinga Exposures Product Safety ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024 April 04, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 04, 2024 Via InvestorPlace AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture April 04, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE April 04, 2024 From AngioDynamics, Inc. Via Business Wire Earnings Scheduled For April 4, 2024 April 04, 2024 Via Benzinga AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement April 02, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. April 01, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024 March 19, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference March 06, 2024 From AngioDynamics, Inc. Via Business Wire Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound March 04, 2024 Via InvestorPlace AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million February 15, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why February 11, 2024 Via Talk Markets Topics Stocks Exposures US Equities AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease January 23, 2024 From AngioDynamics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
